Matches in SemOpenAlex for { <https://semopenalex.org/work/W2139143782> ?p ?o ?g. }
- W2139143782 endingPage "1739" @default.
- W2139143782 startingPage "1731" @default.
- W2139143782 abstract "The costs and side effects of several antiandrogen therapies for advanced prostate cancer differ substantially. We estimated the cost-effectiveness of antiandrogen therapies for advanced prostate cancer.We performed a cost-effectiveness analysis using a Markov model based on a formal meta-analysis and literature review. The base case was assumed to be a 65-year-old man with a clinically evident, local recurrence of prostate cancer. The model used a societal perspective and a time horizon of 20 years. Six androgen suppression strategies were evaluated: diethylstilbestrol (DES), orchiectomy, a nonsteroidal antiandrogen (NSAA), a luteinizing hormone-releasing hormone (LHRH) agonist, and combinations of an NSAA with an LHRH agonist or orchiectomy. Outcome measures were survival, quality-adjusted life years (QALYs), lifetime costs, and incremental cost-effectiveness ratios.DES, the least expensive therapy, had a discounted lifetime cost of $3600 and the lowest quality-adjusted survival, 4.6 QALYs. At a cost of $7000, orchiectomy was associated with 5.1 QALYs, resulting in an incremental cost-effectiveness ratio of $7500/QALY relative to DES. All other strategies-LHRH agonists, NSAA, and both combined androgen blockade strategies-had higher costs and lower quality-adjusted survival than orchiectomy. These results were sensitive to the quality of life associated with orchiectomy and the efficacy of combined androgen blockade, and they changed little when prostate-specific antigen results were used to guide therapy. Under a wide range of other assumptions, the cost-effectiveness of orchiectomy relative to DES was consistently less than $20 000/QALY. Androgen suppression therapies were most cost-effective if initiated after patients became symptomatic from prostate metastases.For men who accept it, orchiectomy is likely to be the most cost-effective androgen suppression strategy. Combined androgen blockade is the least economically attractive option, yielding small health benefits at high relative costs." @default.
- W2139143782 created "2016-06-24" @default.
- W2139143782 creator A5049163875 @default.
- W2139143782 creator A5083651358 @default.
- W2139143782 creator A5086104704 @default.
- W2139143782 date "2000-11-01" @default.
- W2139143782 modified "2023-10-10" @default.
- W2139143782 title "Cost-Effectiveness of Androgen Suppression Therapies in Advanced Prostate Cancer" @default.
- W2139143782 cites W1272283096 @default.
- W2139143782 cites W1516164516 @default.
- W2139143782 cites W1896816349 @default.
- W2139143782 cites W1970881307 @default.
- W2139143782 cites W1971120796 @default.
- W2139143782 cites W1972777925 @default.
- W2139143782 cites W1974518923 @default.
- W2139143782 cites W1974964259 @default.
- W2139143782 cites W1979099938 @default.
- W2139143782 cites W2004969755 @default.
- W2139143782 cites W2014145760 @default.
- W2139143782 cites W2038415989 @default.
- W2139143782 cites W2040909327 @default.
- W2139143782 cites W2043898347 @default.
- W2139143782 cites W2062964819 @default.
- W2139143782 cites W2064213519 @default.
- W2139143782 cites W2068208650 @default.
- W2139143782 cites W2068407303 @default.
- W2139143782 cites W2071879495 @default.
- W2139143782 cites W2079769713 @default.
- W2139143782 cites W2087307657 @default.
- W2139143782 cites W2108368247 @default.
- W2139143782 cites W2121847561 @default.
- W2139143782 cites W2123927174 @default.
- W2139143782 cites W2147348598 @default.
- W2139143782 cites W2160410432 @default.
- W2139143782 cites W2164654252 @default.
- W2139143782 cites W2165763581 @default.
- W2139143782 cites W2165812964 @default.
- W2139143782 cites W2324407881 @default.
- W2139143782 cites W238138266 @default.
- W2139143782 cites W2401434096 @default.
- W2139143782 cites W2420088703 @default.
- W2139143782 cites W2617245288 @default.
- W2139143782 cites W603357331 @default.
- W2139143782 cites W149271758 @default.
- W2139143782 doi "https://doi.org/10.1093/jnci/92.21.1731" @default.
- W2139143782 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11058616" @default.
- W2139143782 hasPublicationYear "2000" @default.
- W2139143782 type Work @default.
- W2139143782 sameAs 2139143782 @default.
- W2139143782 citedByCount "143" @default.
- W2139143782 countsByYear W21391437822012 @default.
- W2139143782 countsByYear W21391437822013 @default.
- W2139143782 countsByYear W21391437822014 @default.
- W2139143782 countsByYear W21391437822015 @default.
- W2139143782 countsByYear W21391437822016 @default.
- W2139143782 countsByYear W21391437822017 @default.
- W2139143782 countsByYear W21391437822018 @default.
- W2139143782 countsByYear W21391437822019 @default.
- W2139143782 countsByYear W21391437822020 @default.
- W2139143782 countsByYear W21391437822021 @default.
- W2139143782 countsByYear W21391437822022 @default.
- W2139143782 crossrefType "journal-article" @default.
- W2139143782 hasAuthorship W2139143782A5049163875 @default.
- W2139143782 hasAuthorship W2139143782A5083651358 @default.
- W2139143782 hasAuthorship W2139143782A5086104704 @default.
- W2139143782 hasBestOaLocation W21391437821 @default.
- W2139143782 hasConcept C112930515 @default.
- W2139143782 hasConcept C121608353 @default.
- W2139143782 hasConcept C126322002 @default.
- W2139143782 hasConcept C126894567 @default.
- W2139143782 hasConcept C143998085 @default.
- W2139143782 hasConcept C2776235491 @default.
- W2139143782 hasConcept C2777899217 @default.
- W2139143782 hasConcept C2777911890 @default.
- W2139143782 hasConcept C2778043895 @default.
- W2139143782 hasConcept C2778559712 @default.
- W2139143782 hasConcept C2779322244 @default.
- W2139143782 hasConcept C2780192828 @default.
- W2139143782 hasConcept C2781440318 @default.
- W2139143782 hasConcept C3019080777 @default.
- W2139143782 hasConcept C64332521 @default.
- W2139143782 hasConcept C71315377 @default.
- W2139143782 hasConcept C71924100 @default.
- W2139143782 hasConceptScore W2139143782C112930515 @default.
- W2139143782 hasConceptScore W2139143782C121608353 @default.
- W2139143782 hasConceptScore W2139143782C126322002 @default.
- W2139143782 hasConceptScore W2139143782C126894567 @default.
- W2139143782 hasConceptScore W2139143782C143998085 @default.
- W2139143782 hasConceptScore W2139143782C2776235491 @default.
- W2139143782 hasConceptScore W2139143782C2777899217 @default.
- W2139143782 hasConceptScore W2139143782C2777911890 @default.
- W2139143782 hasConceptScore W2139143782C2778043895 @default.
- W2139143782 hasConceptScore W2139143782C2778559712 @default.
- W2139143782 hasConceptScore W2139143782C2779322244 @default.
- W2139143782 hasConceptScore W2139143782C2780192828 @default.
- W2139143782 hasConceptScore W2139143782C2781440318 @default.
- W2139143782 hasConceptScore W2139143782C3019080777 @default.
- W2139143782 hasConceptScore W2139143782C64332521 @default.